Loading...
StocksRunner logo
 
 
BELLUS Health
14.63
+0.14%
 
BLU BELLUS Health
Last Price
Change
14.63
 
+0.14%
 
 
 

 
Sentiment
 
  Login to display
 
 

14.43

7.6

8.08

7.99

 
 
1m
3m
6m
1y
 

Summary

BELLUS Health (BLU) still has no score becuse there is not enough information which allows us to analyze the activity of the stock over a period of time
 

Risk Analysis

Risk Analysis

 Enter oversold territory

 
 

Analysts Opinion

Click on the category for more information
 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.50
 

StocksRunner

 Has been gaining momentum

StocksRunner

 Enter oversold territory

 

Activity

×
 

Activity

3.88
 
 

Future

×
 

Future

NA
 
 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 

Street Consensus

Buy
Opinion
Trend
Score
Potential
Score
 
88%
NA
75%
NA
 
On Track
On Track
On Track
 

Street Opinion 

Street view is extremely ish and have negative views on the near-term outlook

 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
Positive vs Negative
 
88%
13%
Positive
Negative
21 out of 24
events present
3 out of 24
events present
 

 
Events Calendar
Click for more information
 
May
S
M
T
W
T
F
S
June
S
M
T
W
T
F
S
 
Highlights
Last
Modify
Closing
Price
%
Change

 
Top Headlines

why shares of bellus health skyrocketed this week. what happened shares of bellus health (nasdaq: blu) jumped 105.1% this week as of thursday afternoon according to data provided by s&p global market intelligence. the company which received a $

Thu Apr 20, 2023

Activity
Momentum

bellus health (blu) stock up 99% on $2b buyout offer from gsk. bellus healthblu and gsk plc gsk announced that the former got an offer to be acquired by the latter for $14.75 per share of common stock in cash representing an approximat

Wed Apr 19, 2023

Activity
Momentum

canada stocks-toronto market extends winning streak on soft landing hopes. canadas main stock market rose on tuesday to its highest closing level in two months as easing inflation raised prospects of the domestic economy avoiding recession and s

Tue Apr 18, 2023

Activity

canada stocks-tsx tracks best winning streak since jan. bellus health soars. canadian stocks rose on tuesday after consumer price data showed signs of slowing inflation while shares of bellus health nearly doubled on gsks buyout deal.

Tue Apr 18, 2023

Activity
Momentum

why bellus health stock is rocketing higher today. what happened shares of bellus health (nasdaq: blu) were up by a whopping 98.9% as of 10:19 a.m. et tuesday morning. the big gain came in response to a $2 billion buyout agreement with british

Tue Apr 18, 2023

Activity

bellus health soars 98% as gsk joins buyout bonanza with $2 billion deal.

Tue Apr 18, 2023

Activity
Momentum

canada stocks-precious metal miners lift tsx higher. bellus health soars. canadas main stock opened higher on tuesday supported by gains in precious metal miners on better-than-forecast growth data from china while shares of bellus health nearly

Tue Apr 18, 2023

Activity
Momentum

gsk to strengthen specialty medicines and respiratory pipeline with $2b bellus health acquisition. ) has agreed tothe late-stage biopharmaceutical company

Tue Apr 18, 2023

Activity

bellus health sunrun and other big stocks moving higher in tuesdays pre-market session. United States stock futures traded higher this morning. here are some big stocks recording gains in today&rsquo.s pre-market trading session. ) shares jumped 97.5%

Tue Apr 18, 2023

Activity

gsk to buy bellus health in us$2.0 bln deal. (rttnews) - gsk plc (gsk gsk.l) agreed to buy bellus health inc. (blu blu.to) a canada-based late-stage biopharmaceutical company working to better the lives of patients suffering from refractory chro

Tue Apr 18, 2023

Activity

gsk to buy canadas bellus health for $2 bln. gsk plc will buy canada-based late-stage biopharma company bellus health inc in an all-cash deal for $2 billion the companies said in a joint statement on tuesday.

Tue Apr 18, 2023

Activity

heres why bellus (blu) is poised for a turnaround after losing -15.33% in 4 weeks. a downtrend has been apparent in bellus health (blu) lately with too much selling pressure. the stock has declined 15.3% over the past four weeks. howev

Thu Apr 6, 2023

Momentum

bellus: phase 1 study establishes proof of concept for developing er formulation of camlipixant. (rttnews) - bellus health inc. (blu blu.to) reported positive data from its phase 1 bioavailability equivalence study evaluating a once-daily extend

Wed Apr 5, 2023

Activity

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our daily BLU alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

 
Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

 
Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
About Us

Log In

Sign Up

Contact Us

Terms of use

Privacy Policy

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
StocksRunner

StocksRunner

Get the pulse of the market

 
StocksRunner

BLU BELLUS Health

Last Price
14.63
Change
+0.14%
 

Summary

BELLUS Health (BLU) still has no score becuse there is not enough information which allows us to analyze the activity of the stock over a period of time

 
 
14.43
7.6
8.08
7.99
 
 
1m
3m
6m
1y
 
Sentiment
 

  Login to display

Risk Analysis

Risk Analysis

 Enter oversold territory

 
 
 
 
Street Consensus
 
Buy
Opinion
Trend
Score
Potential
Score
 
NA
75%
NA
On Track
On Track
On Track
 
88%
13%
Positive
Negative
21 out of 24
events present
3 out of 24
events present
 

Street Opinion

Street view is extremely ish and have negative views on the near-term outlook

 
 
Analysts Opinion
Hover the category for more information
 
 

Earnings

×
 

Earnings

NA
 
 
 

Rating

×
 

Rating

NA
 
 

Momentum

×
 

Momentum

3.50
 

StocksRunner

 Has been gaining momentum

StocksRunner

 Enter oversold territory

 

Activity

×
 

Activity

3.88
 
 

Future

×
 

Future

NA
 
 
 

Analysts Opinion

Analysts opinion is negative and it remained unchanged from the past 3 months

 
 
 
 
 
Events Rating
 
Very Bullish
Bullish
Neutral
Bearish
Very Bearish
 
 
Risk Level
 
 
 

Events Calendar

Hover for information

 
May
 
S
M
T
W
T
F
S
 
June
 
S
M
T
W
T
F
S
 
 
 
 
Highlights
Last
Modify
Closing
Price
%
Change

 
 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

FIND US ON

StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our daily BLU Alerts

Enter your email to receive daily alerts

 
Home

Leading Gainers

Upgrades

Downgrades

Top Leaders

Categories

Ipo's

Dividend

Option Activity

Insiders Activity

Institutional Holdings

Tags

New Products

FDA Approvals

Agreements

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
 
 
 

Top Headlines